2022 High-cost claims and injectable drug trends analysis

Every year, our parent company--Sun Life-- produces an annual report on high cost claims. In this webinar, our colleagues will discuss the latest findings, including the top claim conditions, million-dollar claims, injectable drugs, and trends we are seeing since the COVID-19 pandemic began.